Diabetes mellitus and COVID-19: A review and management guidance for South Africa

A Coetzee; J J Taljaard; S S Hugo; M Conradie; M Conradie-Smit; J A Dave

Diabetes mellitus and COVID-19: A review and management guidance for South Africa

S Afr Med J. 2020 Jun 18;110(8):761-766.

Authors

A Coetzee¹, J J Taljaard, S S Hugo, M Conradie, M Conradie-Smit, J A Dave

Affiliation

¹ Division of Endocrinology, Department of Medicine, Faculty of Medicine and Health Sciences, Stellenbosch University, Cape Town, South Africa. ankiac@sun.ac.za.

PMID: 32880304

Abstract

This article reviews the association between diabetes mellitus (DM) and COVID-19. We report on the convergence of infectious diseases such as coronavirus infections and non-communicable diseases including DM. The mechanisms for the interaction between COVID-19 and DM are explored, and suggestions for the management of DM in patients with COVID-19 in South Africa are offered.

Publication types

Review

MeSH terms

Angiotensin Receptor Antagonists / therapeutic use
Angiotensin-Converting Enzyme Inhibitors / therapeutic use
Betacoronavirus
COVID-19
Coronavirus Infections / complications
Coronavirus Infections / epidemiology
Coronavirus Infections / therapy*
Diabetes Complications / therapy*
Diabetes Mellitus / drug therapy*
Diabetes Mellitus / epidemiology
Diabetes Mellitus / metabolism
Disease Management
Hospitalization
Humans
Hypoglycemic Agents / therapeutic use*
Pandemics
Pneumonia, Viral / complications
Pneumonia, Viral / epidemiology
Pneumonia, Viral / therapy*
Practice Guidelines as Topic*
SARS-CoV-2
Severity of Illness Index
South Africa / epidemiology

Substances

Angiotensin Receptor Antagonists
Angiotensin-Converting Enzyme Inhibitors
Hypoglycemic Agents